Investor.incyte.com

  1. Home
  2. Investor.incyte.com

Investors Incyte

WEBInvestors. Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate …

Actived: 8 days ago

URL: https://investor.incyte.com/

Incyte Announces FDA Approval of Zynyz™ (retifanlimab …

WEB— First regulatory approval for Incyte PD-1 inhibitor based on the results of the POD1UM-201 trial — Zynyz is also being studied in additional tumor types and in …

Category:  Health Go Health

Incyte Announces U.S. FDA Approval of Opzelura™ …

WEB“With the approval of Opzelura in nonsegmental vitiligo, Incyte has once again delivered a treatment to patients with high unmet medical need who previously …

Category:  Medical Go Health

Incyte Launches The Unseen Journey to Elevate the …

WEBThe Unseen Journey highlights the stories of people living with MPNs who were asked to describe their symptoms and how they impact their lives in their own …

Category:  Health Go Health

Incyte Presents New Late-Breaking Data from Phase 2 …

WEBRandomized Phase 2 study met its primary and secondary endpoints following 16 weeks of treatment across all dosing groups, reinforcing povorcitinib’s …

Category:  Health Go Health

Incyte Announces U.S. FDA Approval of Opzelura™ …

WEB- Opzelura is the first and only topical Janus kinase (JAK) inhibitor approved in the United States - In Phase 3 studies, Opzelura significantly reduced the skin …

Category:  Health Go Health

Incyte Announces Data from Phase 2b Study Evaluating …

WEB- Patients treated with povorcitinib experienced improvements in total body and facial repigmentation; investigational therapy was well tolerated - Results were …

Category:  Health Go Health

Financials Incyte

WEBThe information contained in prior reports should be considered accurate only as of the date of the report. We disclaim any obligation to supplement or update the information in …

Category:  Health Go Health

Incyte Announces Japanese Approval of Pemazyre® …

WEBWILMINGTON, Del. & TOKYO--(BUSINESS WIRE)--Mar. 27, 2023-- Incyte (Nasdaq:INCY) today announced that the Japanese Ministry of Health, Labour and …

Category:  Health Go Health

Incyte Strengthens Research & Development Efforts …

WEBDr. Cagnoni joins Incyte’s Executive Team as President and Head of Research & Development. WILMINGTON, Del.--(BUSINESS WIRE)--May 8, 2023-- …

Category:  Health Go Health

Events & Presentations Incyte

WEBIncyte Investor Presentation: AAD 2024 3.6 MB. Feb 13, 2024. Q4 2023 Financial and Corporate Update Presentation. Q4 2023 Financial and Corporate Update …

Category:  Health Go Health

Incyte Reports 2022 Third Quarter Financial Results and Provides

WEB1 Development collaboration with Cellenkos, Inc. 2 Clinical development of axatilimab in GVHD conducted in collaboration with Syndax Pharmaceuticals.. Other …

Category:  Health Go Health

Incyte and Agenus Announce Global Alliance to Develop Novel …

WEBAlliance to initially focus on four checkpoint modulator programs directed at GITR, OX40, TIM-3 and LAG-3; Incyte to have access to Agenus’ proprietary Retrocyte …

Category:  Health Go Health

Cowen 44th Annual Healthcare Conference Incyte

WEBCowen 44th Annual Healthcare Conference. Mar 4, 2024 at 9:50 AM EST. Click here for Webcast.

Category:  Health Go Health

Incyte to Spotlight More Than 40 Hematology and Oncology …

WEB– Sixteen oral presentations, as well as a plenary session and poster presentations, highlight new advances across eight of the Company’s medicines – …

Category:  Medicine Go Health

Cowen 41st Annual Health Care Conference Incyte

WEBMar 3, 2021 at 2:00 PM EST Investor Contacts. Ben Strain. Head of Investor Relations. [email protected]

Category:  Health Go Health

Incyte Reports 2023 First Quarter Financial Results and Provides

WEB– Total net product revenues of $693 million in Q1'23 (+14% Y/Y) – Jakafi ® (ruxolitinib) net product revenues of $580 million (+7% Y/Y) in Q1'23; raising the bottom …

Category:  Health Go Health

Cowen 43rd Annual Health Care Conference Incyte

WEBMar 6, 2023 at 11:10 AM EST Click here for Webcast. Investor Contacts

Category:  Health Go Health

Incyte to Present at Upcoming Investor Conferences Incyte

WEBWILMINGTON, Del.--(BUSINESS WIRE)--Dec. 12, 2023-- Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences …

Category:  Health Go Health

Top Categories

 › Appendicitis

 › Headaches

 › Gout

 › Women's Health

 › Thyroid

 › Sleep

 › Skin

 › Sexual Health

 › Senior Health

 › Pregnancy

 › Oral Health

 › Neurology

 › Migraine

 › Mental Health

 › Men's Health

 › Menopause

 › Medications

 › Lung Conditions

 › Infectious Disease

 › HIV/AIDS

Popular Searched

 › Myhealth va gov sign in

 › Healthe ichris ess log in

 › Thrive behavioral health courses

 › Nhs health check logon

 › Mental health facilities florida

 › Linkedin rochester regional health hiring

 › Future of gcc health

 › Pet health record booklet

 › Chandler hall health care reviews

 › Drug user health programs

Recently Searched

 › How movement helps mental health

 › Idaho department of health and welfare contact

 › Healthy substitute for french fries

 › How does minecraft affect health

 › Health partners medical equipment bloomington mn

 › Independent health extras replacement form

 › Statistical methods in health literature

 › Uw health nurse on call

 › Mo healthnet for adults

 › Consumer health education courses